Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Revenue: 2020-2025

Historic Revenue for IDEAYA Biosciences (IDYA) over the last 3 years, with Sep 2025 value amounting to $207.8 million.

  • IDEAYA Biosciences' Revenue was N/A to $207.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $226.8 million, marking a year-over-year change of. This contributed to the annual value of $7.0 million for FY2024, which is 70.07% down from last year.
  • Per IDEAYA Biosciences' latest filing, its Revenue stood at $207.8 million for Q3 2025, which was up 2,869.06% from $7.0 million recorded in Q4 2024.
  • Over the past 5 years, IDEAYA Biosciences' Revenue peaked at $207.8 million during Q3 2025, and registered a low of $3.0 million during Q4 2021.
  • Its 3-year average for Revenue is $39.7 million, with a median of $7.4 million in 2023.
  • Its Revenue has fluctuated over the past 5 years, first soared by 230.87% in 2022, then tumbled by 72.94% in 2023.
  • Quarterly analysis of 5 years shows IDEAYA Biosciences' Revenue stood at $3.0 million in 2021, then spiked by 35.79% to $4.0 million in 2022, then fell by 2.49% to $3.9 million in 2023, then soared by 78.48% to $7.0 million in 2024, then reached $207.8 million in 2025.
  • Its Revenue was $207.8 million in Q3 2025, compared to $7.0 million in Q4 2024 and $3.9 million in Q4 2023.